Castle Biosciences CSTL Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's accrued expenses?
- Castle Biosciences (CSTL) reported accrued expenses of $19.11M in Q1 2026.
- How has Castle Biosciences's accrued expenses changed year-over-year?
- Castle Biosciences's accrued expenses increased by 7.0% year-over-year, from $17.86M to $19.11M.
- What is the long-term trend for Castle Biosciences's accrued expenses?
- Over 5 years (2020 to 2025), Castle Biosciences's accrued expenses has grown at a 33.3% compound annual growth rate (CAGR), from $9.11M to $38.29M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.